Zobrazeno 1 - 7
of 7
pro vyhledávání: '"D O Laurence Baker"'
Autor:
Donita Sanders, Sybil Biermann, Dihua Yu, D O Laurence Baker, Jonathan C. Trent, Dafydd G. Thomas, Thomas J. Giordano, Raphael E. Pollock, Vernon K. Sondak
Publikováno v:
Cancer. 103:830-838
BACKGROUND Synovial sarcomas are high-grade soft tissue neoplasms often characterized by a biphasic spindle and epithelioid cell morphology. The majority of synovial sarcomas harbor a specific chromosomal translocation in which the proximal portion o
Autor:
Augusto F. Paulino, J. Morris, Riley Rees, Cornelius J. Mcginn, M.P.H. Timothy M. Pawlik M.D., Deborah S. Cohen, H D O Laurence Baker, Vernon K. Sondak
Publikováno v:
Cancer. 98:1716-1726
BACKGROUND Angiosarcoma is a malignant tumor of vascular endothelial cells that arises in the head and neck. It is a rare, difficult to treat, and lethal tumor. METHODS Clinical data from patients who were diagnosed with angiosarcoma of the scalp bet
Autor:
Edward L. Middleman, Susan M. Talbot, Karen H. Antman, H D O Laurence Baker, Stanley P. Balcerzak, Robert A. Chapman, Nirmala Bhoopalam, Robert N. Taub, Cathryn Rankin
Publikováno v:
Cancer. 98:331-336
BACKGROUND The current study was conducted to assess the activity and toxicity of high-dose ifosfamide and mesna with recombinant human granulocyte–colony-stimulating factor (rhG-CSF), given in an outpatient setting, in the treatment of patients wi
Autor:
Curtis Hayes, D O Laurence Baker, Vernon Sondak, Joseph Mace, J. Sybil Biermann, Cornelius McGinn, Dafydd G. Thomas
Publikováno v:
Cancer. 95:2373-2379
BACKGROUND Desmoid tumor represents a rare monoclonal neoplasm arising from deep musculoaponeurotic structures and may occur sporadically or in association with the familial adenomatous polyposis and Gardner syndromes. Desmoid tumors do not appear to
Autor:
Gary J. Miller, Stephen K. Williamson, E. David Crawford, H D O Laurence Baker, Danika Lew, Stanley P. Balcerzak
Publikováno v:
Cancer. 88:1159-1165
BACKGROUND A previous Southwest Oncology Group study demonstrated a 30% response rate with the combination of cisplatin and mitotane in the treatment of patients with metastatic adrenocortical carcinoma. Several case reports suggested that the combin
Autor:
Thomas R. Fleming, Noboru Oishi, Ronald M. Bukowski, John S. Macdonald, H D O Laurence Baker, Sarah A. Taylor
Publikováno v:
Cancer. 71:322-325
Background. Pancreatic carcinoma responds poorly to conventional chemotherapy. To identify potentially useful agents, a sequence of clinical trials were done. Methods. A series of Phase II randomized trials were done by the Southwest Oncology Group i
Publikováno v:
Cancer. 85:2497-2498